Bentham Science Logo

Track Your Manuscript:


CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 19, 10 Issues, 2020
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

CNS & Neurological Disorders - Drug Targets , Volume 18 - Number 2

Biography   Open Access


Review Article

New Drug Discovery from Medicinal Plants and Phytoconstituents for Depressive Disorders

, 18(2): 92 - 102

Fatma Tuğçe Gürağaç Dereli, Mert Ilhan and Esra Küpeli Akkol*


DOI: 10.2174/1871527317666181114141129



Review Article

A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases

, 18(2): 103 - 114

Jia Zhao*, Mengxia Zhu, Mukesh Kumar, Fung Yin Ngo, Yinghui Li, Lixing Lao and Jianhui Rong


DOI: 10.2174/1871527317666181105093834



Research Article

Xuesaitong May Protect Against Ischemic Stroke by Modulating Microglial Phenotypes and Inhibiting Neuronal Cell Apoptosis via the STAT3 Signaling Pathway

, 18(2): 115 - 123

Fangfang Li , Haiping Zhao, Ziping Han, Rongliang Wang, Zhen Tao, Zhibin Fan, Sijia Zhang, Guangwen Li, Zhigang Chen* and Yumin Luo*


DOI: 10.2174/1871527317666181114140340



Research Article

A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions

, 18(2): 124 - 140

Sunee Sirivichayakul, Buranee Kanchanatawan, Supaksorn Thika, André F. Carvalho and Michael Maes*


DOI: 10.2174/1871527317666181119115532



Research Article

Generation and Characterization of a Functional Nanobody Against Inflammatory Chemokine CXCL10, as a Novel Strategy for the Treatment of Multiple Sclerosis

, 18(2): 141 - 148

Tahereh Sadeghian-Rizi, Mahdi Behdani, Hossein Khanahmad, Hamid Mirmohammad Sadeghi and Ali Jahanian-Najafabadi*


DOI: 10.2174/1871527317666181114134518



Research Article

Cytarabine and Ferric Carboxymaltose (Fe+3) Increase Oxidative Damage and Alter Serotonergic Metabolism in Brain

, 18(2): 149 - 155

David Calderón Guzmán, Norma Osnaya Brizuela, Maribel Ortíz Herrera, Hugo Juárez Olguín*, Armando Valenzuela Peraza, Ernestina Hernández García, Francisca Trujillo Jiménez and Gerardo Barragán Mejía


DOI: 10.2174/1871527318666181128144343


Research Article

Effects of Exercise and Ferulic Acid on Alpha Synuclein and Neuroprotective Heat Shock Protein 70 in An Experimental Model of Parkinsonism Disease

, 18(2): 156 - 169

Mona H. Askar, Abdelaziz M. Hussein*, Soheir F. Al-Basiony, Refka K. Meseha, Emile F. Metias, Mohamed M. Salama, Ashraf Antar and Aya El-Sayed


DOI: 10.2174/1871527317666180816095707





Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
Italy

Biography View Full Editorial Board

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Scopus CiteScore Metrics: 2.72

Advertisement

Coronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog